Eargo 7 vs Elehear Beyond

The Eargo 7 is a premium-priced OTC hearing aid at $2,550, earning a B grade with a SoundScore of 3.4/5 in our lab testing. This invisible-in-ear device ranks #38 of 65 OTC hearing aids tested, placing it in the top 57% of its category. In our testing, the Eargo 7 demonstrates solid speech clarity in quiet environments, scoring 3.1/5—0.33 points above the OTC category average. Own-voice comfort also performs above average at 2.9/5, which is +0.39 points versus typical OTC devices, though only mixed in absolute terms. However, speech understanding in noisy situations is a weakness, scoring just 1.0/5, which falls 0.44 points below the category average. The most notable limitation is music streaming, which scored 0.0/5 in our lab measurements—1.92 points below the OTC average. Feedback handling is solid at 3.8/5 in absolute terms, though this is 0.74 points below the category average of 4.54/5. The Eargo 7 may appeal to users prioritizing a completely invisible design who primarily need help with speech in quieter settings. However, given its premium price point, consumers should note that several lower-priced alternatives in our database achieved higher overall sound scores. Those who frequently stream music or struggle in noisy environments may want to explore other options.

The Elehear Beyond is a behind-the-ear OTC hearing aid priced at $431, earning an A grade with a SoundScore of 4.3/5. This places it in the top 11% of all OTC hearing aids tested, ranking #8 out of 65 devices in its category—a standout result for a budget-tier product. In our lab testing, the Beyond demonstrates particular strength in speech clarity for quiet environments, scoring 4.3/5—a full 1.48 points above the OTC category average. Music streaming quality is another highlight at 3.8/5, measuring 1.88 points above average and delivering solid fidelity for phone audio. Speech understanding in noisy situations scores 2.3/5, which is 0.83 points above the category average but remains mixed in absolute terms—a common limitation among OTC devices. Feedback handling is excellent at 4.5/5, providing stable performance during typical use. Own-voice comfort scores 2.6/5, slightly above the category average but still in mixed territory, which may be noticeable for some users during conversation. The Beyond earned a 2024 Expert's Choice Award and represents strong value in the budget OTC segment. It outperforms several same-price competitors including the Apple AirPods Pro 2 and Zepp Clarity Omni. This device is best suited for those seeking reliable speech clarity in quieter settings and quality streaming audio without the higher cost of prescription alternatives.